登录系统
作者:Jin(Bei),Ding(Ke),Pan(Jingxuan) 期刊:Mol Cancer Ther 出版时间:2015-01-02
...CCND1). Moreover, ponatinib was highly active against xenografted D816V KIT tumors in nude mice and ...
作者:Salvi(Samanta),Calistri(Daniele),Gurioli(Giorgia),Carr… 期刊:Int J Mol Sci 出版时间:2015-04-10
...CCND1, CCND2, CDK4, MDM2, AURKB, ERBB2, TOP2A, AURKA, AR and BRAF) using multiplex ligation probe am...
作者:Pezzolo(Elisa),Modena(Yasmina),Corso(Barbara),Giusti(P… 期刊:Eur J Clin Pharmacol 出版时间:2016-01-20
...CCND1) and inflammation (SOD2, TGFB1)/immunity (IL13) pathways, but with no firm conclusion. All the...
作者:Fang(Zhou),Zhou(Linuo),Jiang(Songmin),Cao(Lihuan),Yu(L… 期刊:PLoS One 出版时间:2016-01-19
...CCND1), EGF, matrix metalloproteinase-7 (MMP7), aldose reductase-like 1 (AKR1B10), cell surface-asso...
作者:Guest(Stephen T),Kratche(Zachary R),Bollig-Fischer(Ali… 期刊:Exp Cell Res 出版时间:2015-05-11
...CCND1 as well as regions where the driver oncogene is unknown. In this study, we integrated RNAi-bas...
作者:Dufresne(Armelle),Paturel(Marie),Alberti(Laurent),Phil… 期刊:Cancer Sci 出版时间:2015-08-25
...CCND1, VEGFA, and RB1. These results were confirmed in the independent validation cohort: hierarchic...
作者:Ross(J S),Wang(K),Elkadi(O R),Tarasen(A),Foulke(L),She… 期刊:J Clin Pathol 出版时间:2014-12-12
...CCND1. The most common non-actionable genomic alterations were alterations in TP53 (86% of SCLC case...
作者:Yao(Yan-dan),Sun(Tian-meng),Huang(Song-yin),Dou(Shuang… 期刊:Sci Transl Med 出版时间:2012-08-09
...CCND1, and AKT siRNAs was more effective than an equivalent dose of PLK1-siRNAs alone. These data su...
作者:Capurso(Gabriele),Festa(Stefano),Valente(Roberto),Pici… 期刊:J Mol Endocrinol 出版时间:2012-09-26
...CCND1) oncogene has been described. As for TSGs, P53 (TP53), DPC4/SMAD4 and RB (RB1) are not implica...
作者:Almeida(Madson Q),Azevedo(Monalisa F),Xekouki(Paraskev… 期刊:J Clin Endocrinol Metab 出版时间:2012-06-11
...CCND1, CTNNB1, LEF1, LRP5, WISP1, and WNT3) were overexpressed in PRKAR1A-mutant lesions.,WGEP analy...
山东省济南市章丘区文博路2号 齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号大学科技园北区F座4单元2楼
电话: 0531-88819269
E-mail: product@genelibs.com
关注微信订阅号,实时查看信息,关注医学生物学动态。